Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
Patent 7192612 Issued on March 20, 2007. Estimated Expiration Date: July 6, 2024. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/729, Containing or obtained from Camellia (e.g., tea, including green or black tea, etc.)424/760, Containing or obtained from Capsicum (e.g., chili pepper, cayenne pepper, red pepper, etc.)424/468, Sustained or differential release type514/456, Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.)514/732, Polycyclo ring system (e.g., naphthols, etc.)514/738, Polyhydroxy426/638Spice, herb, or condiment thereof
The invention described herein encompasses methods and compositions of preventing or treating cancer comprising the administration of a combination of therapeutically effective amount of catechins, a group of polyphenols found in green tea, and Capsicum extracts. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). The unique compositions of the invention contain various combinations of the catechins and Capsicum extracts, in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses the varying modes of administration of the therapeutic compounds, including a formulation which may be used as a therapeutic compound for the treatment of cancer or as a dietary supplement for the prevention of cancer.
Other References
Ahmad et al. (1998) “Cancer Chemoprevention by Tea Polyphenols,” Nutrition and Chemical Toxicity, John Wiley and Sons, Sussex, England, pp. 301-343.
Ahmad et al. (1999) “Green Tea Polyphenols and Cancer: Biologic Mechanisms and Practical Implications,” Nutr. Rev. 57:78-83.
Ahmad et al. (Dec. 1997) “Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells,” J. Nat. Cancer Inst. 89:1881-1886.
Brightman et al. (1992) “A Growth Factor- and Hormone-Stimulated NADH Oxidase from Rat Liver Plasma Membrane,” Biochim. Biophys. Acta. 1105:109-117.
Brown et al. (1969) “Butyramide-utilizing Mutants of Pseudomonas aeruginosa 8602 which Produce an Amidase with Altered Substrate Specificity,” J. Gen. Microbiol. 57(2):273-285.
Bruno et al. (1992) “Stimulation of NADH Oxidase Activity from Rat Liver Plasma Membranes by Growth Factors and Hormones is Decreased or Absent with Hepatoma Plasma Membranes,” Biochem J. 284:625-628.
Caterina et al. (2001) “The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway,” Annu. Rev. Neurosci. 24:487-517.
Chan et al. (1997) “Inhibition of Inducible Nitric Oxide Synthase Gene Expresion and Enzyme Activity by Epigallocatechin Gallate, A Natural Product from Green Tea,” Biochem. Pharmacol. 54:1281-1286.
Chen et al. (1998) “Green Tea Epigallocatechin Gallate Shows a Pronounced Grpwth Inhibitory Effect on Cancerous Cells but not on Their Normal Counterparts,” Cancer Lett. 129:173-179.
Chen et al. (1996) “Tamoxifen Induces TGF-β-1 Activity and Apoptosis of Human MCF-7 Breast Cancer Cells in Vitro,” J. Cell. Biochem. 61:9-17.
Chueh et al. (1997) “A 33.5-kDa Heat- and Protease-Resistant NADH Oxidase Inhibited by Capsaicin from Sera of Cancer Patients,” Arch. Biochem. Biophys. 342:38-44.
Chueh et al. (1997) “The Hormone-responsive NADH Oxidase of the Plant Plasma Membrane Has Properties of a NADH: Protein Disulfide Reductase,” J. Biol. Chem. 272:11221.
DeHann et al. (1997) “NADH Oxidase Activity Present on Both the External and Internal Surfaces of Soybean Plasma Membranes,” Biochim. Biophys. Acta. 1328:99-108.
Dong et al. (Oct. 1997) “Inhibition of Tumor Promoter-induced Activator Protein 1 Activation and Cell Transformation by Tea Polyphenols, (-)-Epigallocatechin Gallate, and Theaflavins,” Cancer Res. 57:4414-4419.
Fujiki et al. (1998) “Cancer Inhibition by Green Tea,” Mutat. Res. 402:307-310.
Holzer et al. (1979) “Nociceptive Threshold After Neonatal Capsaicin Treatment,” Eur. J. Pharm. 58:511-514.
Jancso et al. (1980) “Effect of Capsaicin on Morphine Analgesia Possible Involvement of Hypothalamic Structures,” Naunyn-Schmiedeberg's Arch. Pharmacol. 311:285-288.
Khan et al. (1988) “Inhibition of the Skin Tumorigenicity of (±)-7β, 8α-Dihydroxy-9, 10α-Epoxy-7,8,9,10-Tetrahydrobenzo[a]pyrene by Tannic Acid, Green Tea Polyphenols and Quercetin in Sencar Mice,” Cancer Lett. 42:7-12.
Kishi et al. (1999)“The Plasma Membrane NADH Oxidase of HeLa Cells has Hydroquinone Oxidase Activity,” Biochem. Biophys. Acta. 1412:66-77.
Liang et al. (1997) “Suppression of Extracellular Signals and Cell Proliferation Through EGF Receptor Binding by(-)-Epigallocation Gallate in Human A431 Epidermoid Carcinoma Cells,” J. Cell. Biochem. 67:55-65.
Liao et a. (1995) “Growth Inhibition and Regression of Human Prostate and Breast Tumors in Athymic Mice by Tea Epigallocatechin Gallate,” Cancer Lett. 96:239-243.
Lin et al. (Sep. 1997) “(—)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB,” Mol. Pharmacol. 52:465-472.
Morré (1994) “Hormone- and Growth Factor-Stimulated NADH Oxidase,” J. Bioenerg. Biomemb. 26:421-433.
Morré (1998)“A Multifunction Ectoprotein of the Eukaryotic Cell Surface,” in Plasma Membrane Redox Systems and their Role in Biological Stress and Disease, Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 121-156.
Morré et al. (1995) “Mechanism of Killing of HeLa Cells by the Antitumor Sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984),” Protoplasma 184:188-195.
Morré et al. (Mar. 1995) “Capsaicin Inhibits Preferentially the NADH Oxidase and Growth of Transformed Cells in Culture,” Proc. Natl. Acad. Sci. U.S.A. 92:1831-1835.
Morré et al. (1995) “The Antitumor Sulfonylurea N-(4methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) Inhibits NADH Oxidase Activity of HeLa Plasma Membranes,” Biochim. Biophys. Acta. 1240:11-17.
Morré et al. (1996) “Capsaicin Inhibits Plasma Membrane NADH Oxidase and Growth of Human and Mouse Melanoma Lines,” Eur. J. Can. 32A:1995-2003.
Morré et al. (1997) “Is the Drug-Responsive NADH Oxidase of the Cancer Cell Plasma Membrane a Molecular Target for Adriamycin,” J. Biomemb. Bioeng. 29:269-280.
Morré et al. (1991) “NADH Oxidase of Plasma Membranes,” J. Bioenerg. Biomemb. 23:469-489.
Komori et al. (1993) “Anticarcinogenic Activity of Green Tea Polyphenols,” Jpn. J. Clin. Oncol. 23:186-190.
Paschka et al. (1998) “Induction of Apoptosis in Prostate Cancer Cell Lines by the Green Tea Component, (-)-Epigallocatechin-3-Gallate,” Cancer Lett. 130:1-7.
Piazza et al. (Jul. 1995) “Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis,” Cancer Res. 55:3110-3116.
Sadzuka et al. (Jan. 1998) “Modulation of Cancer Chemotherapy by Green Tea,” Clin. Cancer Res. 4:153-156.
Stoner et al. (1995) “Polyphenols as Cancer Chemopreventive Agents,” J. Cell. Biochem. 22:169-180.
Suganuma et al. (Jan. 1999) “Synergistic Effects of (-)-Epigallocatechin Gallate with (-)-Epicatechin, Sulindac, or Tamoxifen on Cancer-preventive Activity in the Human Lung CancerCell Line PD-9,”Can. Res. 59:44-47.
Sugiyama et al (1998) “Enhancing Effects of Green Tea Components on the Antitumor Activity of Adriamycin Against M5076 Ovarian Sarcoma,” Can. Lett. 133:19-26.
Sugunama et al. (Oct. 1998) “Wide Distribution of [3H](-)-Epigallocatechin Gallate, a Cancer Preventive Tea Polyphenol, in Mouse Tissue,” Carcinogenesis 19:1771-1776.
Sugunama et al. (Aug. 1996) “A New Process of Cancer Prevention Mediated Through Inhibition of Tumor Necrosis Factor Alpha Expression,” Can. Res. 56:3711-3715.
Sun et al. (Nov. 1987) “NADH Diferric Transferrin Reductase in Liver Plasma Membrane,” J. Biol. Chem. 262:15915-15921.
Wang et al. (Feb. 1989) “Protection Against Polycyclic Aromatic Hydrocarbon-Induced Skin Tumor Initiation in Mice by Green Tea Polyphenols,” Carcinogenesis 10:411-415.
Wang et al. (1994) “Inhibitory Effects of Black Tea, Green Tea, Decaffeinated Black Tea, and Decaffeinated Green Tea on Ultraviolet B Light-induced Skin Carcinogenesis in 1,12-Dimethylbenz[a]anthracene-initiated SKH-1 Mice,” Cancer Res. 54:3428-3435.
Weisburger (1997) “Tea and Health: A Historical Prospective,” Cancer Lett. 114:315-317.
Wright et al. (Jun. 1994) “Inhibition of Apoptosis as a Mechanism of Tumor Promotion,” FASEB J. 8:654-660.
Yaksh et al. (1979) “Intrathecal Capsaicin Depletes Substance P in Rat Spinal Cord and Produces Prolonged Thermal Analgesia,” Science 206:481-483.
Yang et al. (Apr. 1998) “Inhibition of Growth and Induction of Apoptosis in Human Cancer Cell Lines by Tea Polyphenols,” Carcinogenesis 19:611-616.
http://www.capsibiol-t.com Capsibiol-T: Green Tea and Capsicum Anticancer Supplement.
http://www.newcancerresearch.com New Cancer Research—Capsibiol-T® Targets and Inhibits the tNOX Protein of Cancer Cells.
July 6, 2024. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
